Register 3 for the price of 2 with the coupon code rcdvb!

Matthew Ferber, Assistant Professor of Laboratory Medicine & Pathology, Mayo Clinic
Andrew Grupe, Senior Director, Pharmacogenomics, Celera
Tina Hambuch, Scientific Liaison, Illumina Clinical Services Laboratory
Thomas Scholl, Vice President of R&D, Integrated Genetics / LabCorp

Yair Benita, Senior Computation Biologist, Merck
Paul Billings, Chief Medical Officer, Lifetechnologies
Peter Blume-Jensen, CSO, Metamark Genetics
James Cai, Head, Disease & Translational Informatics, Roche
Stephanie Chissoe, Director and Acting Head of Genetics, GlaxoSmithKline
Alex Gaither, Senior Research Investigator, Cancer Biology and Biologics Group Leader, Novartis Institutes for BioMedical Research, Inc.
Rudolf Grimm, Director Science & Technology, Agilent Technologies
Richard Head, Research Associate Professor, Department of Genetics, Washington University
Stephen Johnston, Director, Center for Innovations in Medicine, Biodesign Institute, Arizona State University
Urban Kiernan, Senior Scientist, Thermo Fisher Scientific
Johanna Lahdenranta, Principal Scientist, Merrimack Pharmaceuticals
Martin Latterich, Professor, Proteogenomics Research Institute for Systems Medicine
Andrew Munk, MRM Proteomics Inc
Mike Milburn, CSO, Metabolon
Yoshiya Oda, Biomarkers and Personalized Medicine Core Function Unit, Eisai
Emanuel Petricoin, Professor, Applied Proteomics & Molecular Medicine, George Mason University
Paul Rejto, Director and Head of Computation Biology, Oncology Research Unit, Pfizer
Heinrich Roder, CTO and Director, Biodesix
Tristan Sissung, Staff Scientist and Head of the Pharmacogenetics Core, Clinical Pharmacology Program, National Cancer Institute
Debraj Guha Thakurta, Senior Scientist II & Group Leader, Dendreon
Peter Tolias, Director, Bioinnovation Program, Stevens Institute of Technology
Markus Warmuth, President and CEO, H3Biomedicine
Eric Yang, Informatics Scientist, Johnson & Johnson
Kate Zhang, Senior Director, Transitional Research, Genzyme, a Sanofi company

Alexander Balatsky, Scientist, Center for Integrated Nanotechnologies, Los Alamos National Labs
Shawn Burgess, Senior Investigator, National Human Genome Research Institute
Massimiliano Di Ventra, Professor of Physics, University of California, San Diego
Jason Dwyler, Assistant Professor, Department of Chemistry, University of Rhode Island
Malek Faham, CSO, Sequenta
Jens Gundlach, Professor, Department of Physics, University of Washington
Ki-bum Kim, Professor, Department of Materials and Science Engineering, Seoul National University
Predrag Krstic, Senior Scientist, JICS, University of Tennessee
Shashikant Kulkarni, Head Clinical Genomics & Medical Director, WashU
Joseph Lakowicz, Director, Center for Fluorescence Spectroscopy, University of Maryland School of Medicine
Bill LaRochelle, Head of Healthcare and Business Development, Roche 454
Kaji Noritada, Associate Professor, Department of Applied Chemistry, Nagoya University
Walter Reisner, Assistant Professor of Pathology, McGill University
Gary Schroth, Senior Director, Expressions Applications R&D, Illumina
Kári Stefánsson, CEO, deCODE genetic
Todd Smith, Senior Leader Research and Applications, Perkin Elmer / Geospiza
Masateru Taniguchi, Professor, The Institute of Scientific and Industrial Research, Osaka University
John Thompson, Head of Applications Development, NABsys
Ali Torkamani, Director of Drug Discovery, Scripps Translational Science Institute
Xu Xun, Deputy Director of BGI Research, BGI

Bernard Andruss, Director, Collaborations and Business Development, Asuragen
Paul Beresford, VP Business Development and Strategic Marketing, Biodesix
Elaine Cheung, Director, Business Development, Genomic Health
Nong Chen, Director of Scientific Collaborations, BGI Americas
Alan Dance, Vice President, Marketing, NuGEN Technologies
Joseph Ferrara, President, Boston Healthcare
Gary Gustavsen, Health Advances
Karin A. Gregory, Furman Gregory Deptula
Kevin Hrusovsky, President of Lifesciences, PerkinElmer
Martin LeBlanc, President / CEO, Caprion Proteomics
Elissa Levin, Vice President of Genomic Services, Navigenics
Gabriela Lavezzari, Director, Extramural Development, Medco Research Institute, Express Scripts
Lita Nelsen, Director of the Technology Licensing Office, Massachusetts Institute of Technology
Michael Pollack, Co-founder, Advanced Liquid Logic
Hathaway Pease Rusell, Partner, Foley Hoag LLP
Richard Resnick, GenomeQuest
Rhonda Tannenbaum, VP of Business Development, Ontario Genomics Institute
Patrick Terry, Principle, Scientific Advisors LLC
Eric Wassman, Chief Medical Officer, Generation Health
Richard Watts, Senior Director CDx Partnerships Qiagen

Peter Brandt, Principal Scientist, Beactica
Alex Bullock, Principal Investigator and Group Head / PI Structural Genomics Consortium, University of Oxford
Thomas Chan, Chief Scientific Officer, Discovery and Early Development, ArQule
Shaoqing Chen, Senior Principal Scientist, Roche
Alexei Degterev, Ph.D., Assistant Professor, Biochemistry, Tufts University
Xianming Deng, Principal Investigator, Xiamen University
Erin DiMauro, Ph.D., Principal Scientist, Therapeutic Discovery, Amgen
Thomas Engler, Senior Research Advisor, Discovery Chemistry Research and Technologies, Eli Lilly
Said Goueli, Ph.D., Research Fellow, Cell Signaling and Cell Analysis Group, Promega
Richard Lewis, Principal Scientist, Amgen
Min Liu, Assistant Director, the Laboratory of Drug Discovery, Harvard Neurodiscovery Center
Yan Lou, Principal scientist, Discovery Chemistry, Roche
Dustin J. Maly, Assistant Professor, Chemistry, University of Washington, Seattle
Jeffrey Peterson, Associate Professor, Fox Chase Cancer Center
Jennifer Piesvaux, MS, BS, Research Biochemist, In vitro Pharmacology: Biochemistry/ Biophysics, Merck
Leo Price, Ph.D., Principal Investigator, Leiden/Amsterdam Center for Drug Research, Leiden University
Elizabeth Quinn, Ph.D., Marketing Director, LeadHunterSM Discovery Services, DiscoveRX
Gary Schieven, Research Fellow, Immunology Drug Discovery Bristol-Myers-Squibb
Markus Seeliger, Assistant Professor, Pharmacological Sciences, Stonybrook University
Juswinder Singh, Chief Scientific Officer, Avila
Matthew Soellner, Assistant Professor Medicinal Chemistry, University of Michigan
Li Xing, Ph.D., Senior Principal Scientist, Pfizer

Daniel G. Anderson, Ph.D., Associate Professor, Chemical Engineering, Harvard-MIT Division of Health Sciences & Technology, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Sujit K. Basu, Ph.D., Vice President, Formulation, Dicerna Pharmaceuticals
James Cardia, Ph.D., Scientist II, Technology Development, RXi Pharmaceuticals
Pieter R. Cullis, Ph.D., FRSC, Professor, Biochemistry and Molecular Biology, University of British Columbia
Paul Diehl, Ph.D., Director, Business Development, Cellecta
Paloma H. Giangrande, Ph.D., Assistant Professor, Internal Medicine, University of Iowa
Klaus Giese, Ph.D., Chief Scientific Officer, Research and Development, Silence Therapeutics
Benjamin Haley, Ph.D., Scientist, Molecular Biology Department, Genentech
Richard T. Ho, M.D., Ph.D., Executive Vice President, Research and Development, Marina Biotech
Randall W. King, M.D., Ph.D., Associate Professor, Cell Biology, Harvard Medical School
Troels Koch, Vice President and Chief Technology Officer, Santaris Pharma
Devin Leake, Global Director of Research & Development, Genomics, Thermo Fisher Scientific
Dave Rozema, Vice President, Chemistry, Arrowhead Research
Attila Seyhan, Sr. Biomarker Discovery and Development Leader, Biotherapeutics Clinical R&D, Pfizer
Yu Shen, Senior Group Leader, Cancer Research, Abbott
S. Mark Tompkins, Associate Professor, Infectious Diseases, University of Georgia
Ralph A. Tripp, Professor & GRA Chair, Infectious Diseases, University of Georgia
Hua Yu, Ph.D., Associate Chair and Professor, Department of Cancer Immunotherapeutics & Tumor Immunology, Beckman Research Institute at City of Hope Comprehensive Cancer Center

Schahram Akbarian, M.D., Ph.D., Director, Brudnick Neuropsychiatric Research Institute; Professor, Department of Psychiatry, University of Massachusetts Medical School
Hozefa Bandukwala, Instructor, Signaling and Gene Expression, La Jolla Institute of Allergy and Immunology
Olena Barbash, Investigator, Cancer Epigenetics DPU, GlaxoSmithKline
Kun Bi, Ph.D., Senior Staff Scientist, Primary and Stem Cell Systems, Life Technologies
Richard Deth, Professor, Pharmacology, Northeastern University

Guoping Fan, Professor, Human Genetics, University of California, Los Angeles
Jean-Christophe (JC) Harmange, Executive Director, Drug Discovery, Constellation
Johannes Graeff, Ph.D., Brain and Cognitive Neurosciences, Li-Huei Tsai's Lab, The Picower Institute for Learning and Memory, Massachusetts Institute of Technology

Quamrul Hassan, Lab Head, Oncology, Novartis
Tom Heightman, Director, Medicinal Chemistry, Astex Pharmaceuticals

Carsten Hopf, Associate Director Target Discovery & Business Development Technology, Cellzome
Hella Kohlhof, Manager Translational Pharmacology, 4SC
Shidong Jia, Scientist, Genentech
Tamara Maes, Ph.D., Chief Scientific Officer, Research and Development, Oryzon Genomics

Mikel Moyer, Ph.D., Vice President, Molecular Discovery, Epizyme
Peter Ordentlich, Ph.D., Vice President, Translational Medicine, Syndax Pharmaceuticals
Dafydd Owen, Ph.D., Associate Research Fellow, Pfizer
Rab Prinjha, Interim Head of Epinova Epigenetics DPU and Head of Biology, GlaxoSmithKline, UK
Charles W. M. Roberts, M.D., Ph.D., Associate Professor, Pediatric Oncology, Dana-Farber Cancer Institute, Children's Hospital and Harvard Medical School
Y. Geno Shi, Ph.D., Assistant Professor of Medicine; Associate Biochemist, Harvard Medical School; Brigham and Women's Hospital
David Sinclair, Ph.D., Epigenetics in Aging and Age-Related Diseases, Harvard Medical School

Casandra Smith, Ph.D., Professor, Biomedical Engineering, Biology and Pharmacology and Experimental Therapeutics; Director, Molecular Biotechnology Research Laboratory, Boston University
Keith Szulwach, Ph.D., Postdoctoral Fellow, Human Genetics, Emory University School of Medicine
Claes Wahlestedt, M.D. Ph.D., Associate Dean for Therapeutic Innovation; Vice Chair for Research, Psychiatry and Behavioral Sciences; Director, Center for Therapeutic Innovation (CTI), University of Miami Miller School of Medicine